There is also a need to design additional experiments in the context of diabetes aimed at comparing the cardiovascular effects of incretin-based therapies to other glucose-lowering therapies and analyzing in depth the impact such therapies may have on different comorbid conditions associated with this disease, including obesity, hyperlipidemia, high blood pressure, renal failure, and so on.72 In this same conceptual framework, experiments to compare the cardioprotective efficacy of different therapies based on GLP-1 should be considered, particularly because GLP-1R and DPP-4 inhibitors have different actions depending on whether they are assessed in the metabolic or cardiovascular setting.14,72,73 In this regard, mention should be made of the multiple experimental observations attributing a cardioprotective activity to the GLP-1 (936) peptide, whose blood levels may be influenced by the type of incretin-based therapy administered

Enjoy affordable rates with our New Talent Stylistsgifted emerging artists trained in Daireds signature techniques
Based on 125,474 adults with overweight or obesity who newly initiated GLP-1based injectables between January 1, 2018 and December 31, 2023
How to verify authentic GLP-1 medication Verification takes effort, but it is worth every minute